Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
platelet-rich plasma (Vancouver General Hospital)
- Development stage
- Unknown
- Lead developer
- Vancouver General Hospital
- Administration
- Intradermal, Subcutaneous
01
Overview
Platelet-rich plasma (PRP) is an autologous biologic therapy being investigated by Vancouver General Hospital for the treatment of androgenetic alopecia. It is prepared from the patient's own blood through centrifugation to concentrate platelets in plasma, which contains high concentrations of growth factors such as platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), and vascular endothelial growth factor (VEGF). These growth factors are thought to stimulate hair follicle stem cells in the bulge area, promoting hair follicle development and neovascularization. In clinical trials (e.g., NCT02074943), PRP is administered via intradermal or subdermal injections into the scalp, typically in multiple treatment sessions, to promote hair regrowth in patients with androgenetic alopecia.
- Other names
- PRPautologous platelet-rich plasma
02
Targets
EGFR (Epidermal growth factor receptor)FGFR3 (Fibroblast growth factor receptor 3)IGF-1R (Insulin-like growth factor 1 receptor)PDGFRA (Platelet-derived growth factor receptor alpha)TGFBR (TGF-beta receptor)VEGFR (VEGFR family)
Beyond the preview
Go deeper on platelet-rich plasma (Vancouver General Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on platelet-rich plasma (Vancouver General Hospital).